We observed increased SHCBP1 protein levels in tumour cells with escalating doses of DNA-damaging agents (within a cell-lethal dose) exposure, including etoposide (ETOP), cisplatin (CDDP), and radiation (Supplementary Fig. 10A-C). Here, SHCBP1 is linked to neoplasm.